Zobrazeno 1 - 10 of 437 pro vyhledávání: '"Nitz UA"'
1
Akademický článek
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.
Autor: Harbeck N; West German Study Group, Moenchengladbach, Germany.; Department of Gynecology and Obstetrics and CCCMunich, Breast Center, LMU University Hospital, Munich, Germany., Nitz UA; West German Study Group, Moenchengladbach, Germany.; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany., Christgen M; Institute of Pathology, Medical School Hannover, Hannover, Germany., Kümmel S; West German Study Group, Moenchengladbach, Germany.; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.; Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany., Braun M; Breast Center, Rotkreuz Clinics Munich, Munich, Germany., Schumacher C; Breast Center, St Elisabeth Hospital Cologne, Cologne, Germany., Potenberg J; Ev. Waldkrankenhaus Berlin, Berlin, Germany., Tio J; Department of Gynecology, University Hospital Münster, Münster, Germany., Aktas B; Women's Clinic, University Clinics Essen, Essen, Germany.; University Clinics Leipzig, Women's Clinic, Leipzig, Germany., Forstbauer H; Oncology Practice Network Troisdorf, Troisdorf, Germany., Grischke EM; Women's Clinic, University Clinics Tuebingen, Tuebingen, Germany., Scheffen I; West German Study Group, Moenchengladbach, Germany.; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany., Malter W; Department of Obstetrics and Gynecology, Breast Center, University Hospital, Cologne, Germany., von Schumann R; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany., Just M; Oncological Practice, Bielefeld, Germany., Zu Eulenburg C; West German Study Group, Moenchengladbach, Germany.; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg, Hamburg, Germany., Biehl C; Westphalian Brest Center Dortmund, Dortmund, Germany., Kolberg-Liedtke C; Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Women's Clinic, University Clinics Essen, Essen, Germany., Deurloo R; F. Hoffmann-La Roche Ltd, Basel, Switzerland., de Haas S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Kates R; West German Study Group, Moenchengladbach, Germany., Graeser M; West German Study Group, Moenchengladbach, Germany.; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany.; Department of Gynecology, University Medical Center Hamburg, Hamburg, Germany., Wuerstlein R; West German Study Group, Moenchengladbach, Germany.; Department of Gynecology and Obstetrics and CCCMunich, Breast Center, LMU University Hospital, Munich, Germany., Kreipe HH; Institute of Pathology, Medical School Hannover, Hannover, Germany., Gluz O; West German Study Group, Moenchengladbach, Germany.; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany.; University Clinics Cologne, Cologne, Germany.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Aug 01; Vol. 41 (22), pp. 3796-3804. Date of Electronic Publication: 2023 Feb 21.
Zobrazit plný text záznamu
2
Akademický článek
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical Trial.
Autor: Gluz O; West German Study Group, Mönchengladbach, Germany.; Breast Center Niederrhein, Ev. Hospital Bethesda, Mönchengladbach, Germany.; University Clinics Cologne, Cologne, Germany., Nitz UA; West German Study Group, Mönchengladbach, Germany.; Breast Center Niederrhein, Ev. Hospital Bethesda, Mönchengladbach, Germany., Christgen M; Institute of Pathology, Hannover Medical School, Hannover, Germany., Kuemmel S; West German Study Group, Mönchengladbach, Germany.; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.; Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany., Holtschmidt J; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.; Breast Center, St Elisabeth-Krankenhaus Köln-Hohenlind, Cologne, Germany., Schumacher J; Statitistics, Palleos Healthcare GmbH, Wiesbaden, Germany., Hartkopf A; Department of Gynecology and Obstetrics, Tüebingen University Hospital, Tüebingen, Germany., Potenberg J; Ev Waldkrankenhaus Berlin, Berlin, Germany., Lüedtke-Heckenkamp K; Department of Oncology and Hematology, Niels Stensen-Kliniken, Georgsmarienhütte, Germany., Just M; Oncological Practice, Bielefeld, Germany., Schem C; Mammazentrum am Krankenhaus Jerusalem, Hamburg, Germany., von Schumann R; Breast Center Niederrhein, Ev. Hospital Bethesda, Mönchengladbach, Germany., Kolberg-Liedtke C; Department of Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Women's Clinic, University Clinics Essen, Essen, Germany., Eulenburg CZ; West German Study Group, Mönchengladbach, Germany.; Department of Medical Biometry and Epidemiology, University Medical Center Hamburg, Hamburg, Germany., Schinköthe T; Breast Center, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Munich, Ludwig Maximilians University Hospital, Munich, Germany.; CANKADO Service GmbH, Kirchheim bei München, Germany., Graeser M; West German Study Group, Mönchengladbach, Germany.; Breast Center Niederrhein, Ev. Hospital Bethesda, Mönchengladbach, Germany.; Department of Gynecology, University Medical Center Hamburg, Hamburg, Germany., Wuerstlein R; West German Study Group, Mönchengladbach, Germany.; Breast Center, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Munich, Ludwig Maximilians University Hospital, Munich, Germany., Kates RE; West German Study Group, Mönchengladbach, Germany., Kreipe HH; Institute of Pathology, Hannover Medical School, Hannover, Germany., Harbeck N; West German Study Group, Mönchengladbach, Germany.; Breast Center, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Munich, Ludwig Maximilians University Hospital, Munich, Germany.
Publikováno v: JAMA oncology [JAMA Oncol] 2023 Jul 01; Vol. 9 (7), pp. 946-954.
Zobrazit plný text záznamu
3
Akademický článek
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer.
Autor: Nitz UA; West German Study Group, Moenchengladbach, Germany.; Ev. Bethesda Hospital, Breast Center Niederrhein, Moenchengladbach, Germany., Gluz O; West German Study Group, Moenchengladbach, Germany.; Ev. Bethesda Hospital, Breast Center Niederrhein, Moenchengladbach, Germany.; University Clinics Cologne, Women's Clinic and Breast Center, Cologne, Germany., Kümmel S; West German Study Group, Moenchengladbach, Germany.; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.; Clinic for Gynecology with Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany., Christgen M; Medical School Hannover, Institute for Pathology, Hannover, Germany., Braun M; Department of Gynecology, Breast Center, Red Cross Hospital Munich, Munich, Germany., Aktas B; University Clinics Essen, Women's Clinic, Essen, Germany.; University Clinics Leipzig, Women's Clinic, Leipzig, Germany., Lüdtke-Heckenkamp K; Niels Stensen Clinics, Clinics for Oncology, Osnabrück, Germany., Forstbauer H; Oncology Practice Network Troisdorf, Troisdorf, Germany., Grischke EM; University Clinics Tübingen, Women's Clinic, Tuebingen, Germany., Schumacher C; St Elisabeth Hospital, Cologne, Germany., Darsow M; Luisenhospital Duesseldorf, Practice for Senologic Oncology, Duesseldorf, Germany., Krauss K; University Clinics Aachen, Women's Clinic, Aachen, Germany., Nuding B; Ev. Hospital Bergisch Gladbach, Bergisch Gladbach, Germany., Thill M; Markus Hospital, Breast Center, Frankfurt, Germany., Potenberg J; Ev. Waldkrankenhaus Berlin, Berlin, Germany., Uleer C; Gynecologists at Bahnhofsplatz, Hildesheim, Germany., Warm M; City Hospital Holweide, Breast Center, Cologne, Germany., Fischer HH; Ev. Hospital Gelsenkirchen, Gelsenkirchen, Germany., Malter W; University Clinics Cologne, Women's Clinic and Breast Center, Cologne, Germany., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology Cottbus - Senftenberg, the Brandenburg Medical School Theodor Fontane and the University of Potsdam, Neuruppin, Germany., Kates RE; West German Study Group, Moenchengladbach, Germany., Gräser M; West German Study Group, Moenchengladbach, Germany.; Ev. Bethesda Hospital, Breast Center Niederrhein, Moenchengladbach, Germany.; Department of Gynecology, University Medical Center Hamburg, Hamburg, Germany., Würstlein R; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany., Shak S; Exact Science, Inc, Redwood City, CA., Baehner F; Exact Science, Inc, Redwood City, CA., Kreipe HH; Medical School Hannover, Institute for Pathology, Hannover, Germany., Harbeck N; West German Study Group, Moenchengladbach, Germany.; Breast Center, Department of Obstetrics and Gynecology and CCC Munich, LMU University Hospital, Munich, Germany.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Aug 10; Vol. 40 (23), pp. 2557-2567. Date of Electronic Publication: 2022 Apr 11.
Zobrazit plný text záznamu
4
Corrigendum to "De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel": [Annals of Oncology 28 (2017) 2768-2772].
Autor: Nitz UA; West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany., Gluz O; West German Study Group GmbH, Moenchengladabach, Germany; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany; University of Cologne, Cologne, Germany. Electronic address: oleg.gluz@wsg-online.com., Christgen M; Institute of Pathology, Medical School Hannover, Hannover, Germany., Grischke EM; Department of Gynecology and Obstetrics, University Clinics Tuebingen, Tuebingen, Germany., Augustin D; Breast Center Ostbayern, Deggendorf, Germany., Kuemmel S; Breast Center, Clinics Essen-Mitte, Essen, Germany., Braun M; Rotkreuz Clinics Munich Breast Center, Munich, Germany., Potenberg J; Department of Oncology Evangelical Waldkrankenhaus Berlin, Berlin, Germany., Kohls A; Department of Gynecology and Obstetrics, Evangelical Hospital, Ludwigsfelde, Germany., Krauss K; Department of Gynecology and Obstetrics, University Clinics RWTH, Aachen, Germany., Stefek A; Breast Center, Evangelical Hospital Johanniter, Stendal, Germany., Schumacher C; Breast Center, St. Elisabeth Hospital Cologne, Cologne, Germany., Forstbauer H; Oncology Practice Network, Troisdorf, Germany., Reimer T; Department of Gynecology and Obstetrics, University Clinics Rostock, Suedstadt, Germany., Fischer H; Breast Center, Evangelical Hospital Gelsenkirchen, Gelsenkirchen, Germany., Liedtke C; Department of Gynecology and Obstetrics, University Clinics Schleswig-Holstein/Campus Luebeck, Luebeck, Germany; Charite Berlin, Germany., Wuerstlein R; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany., Schumacher J; Palleos Healthcare, Statistics, Wiesbaden, Germany., Kates R; West German Study Group GmbH, Moenchengladabach, Germany., Kreipe H; University of Cologne, Cologne, Germany., Harbeck N; West German Study Group GmbH, Moenchengladabach, Germany; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich, Germany.
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Mar; Vol. 33 (3), pp. 355. Date of Electronic Publication: 2022 Jan 07.
Zobrazit plný text záznamu
6
Akademický článek
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial.
Autor: Nitz UA (AUTHOR), Mohrmann S (AUTHOR), Fischer J (AUTHOR), Lindemann W (AUTHOR), Berdel WE (AUTHOR), Jackisch C (AUTHOR), Werner C (AUTHOR), Ziske C (AUTHOR), Kirchner H (AUTHOR), Metzner B (AUTHOR), Souchon R (AUTHOR), Ruffert U (AUTHOR), Schütt G (AUTHOR), Pollmanns A (AUTHOR), Schmoll HJ (AUTHOR), Middecke C (AUTHOR), Baltzer J (AUTHOR), Schrader I (AUTHOR), Wiebringhaus H (AUTHOR), Ko Y (AUTHOR)
Publikováno v: Lancet. 12/3/2005, Vol. 366 Issue 9501, p1935-1944. 10p.
Zobrazit plný text záznamu
7
Akademický článek
Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
Autor: Hyams DM; Medical Director, Desert Surgical Oncology, Eisenhower Medical Center, Rancho Mirage, California, USA., Bareket-Samish A; BioInsight Ltd., Binyamina, Israel., Rocha JEB; Breast Cancer Department, Instituto Nacional de Cancerología Mexico and Centro Medico ABC, Mexico City, Mexico., Diaz-Botero S; Breast Surgical Oncology Unit, Cancer Center at Clínica Universidad de Navarra, Madrid, Spain., Franco S; Medical Director, Centro de Tratamiento e Investigación sobre el Cáncer, CTIC, Bogotá, Colombia., Gagliato D; Department of Clinical Oncology, Beneficencia Portuguesa de Sao Paulo, San Paulo, Brazil., Gomez HL; Breast Unit Director, OncoSalud, Clinica Delgado, AUNA, Universidad Ricardo Palma, Universidad Peruana Cayetano Heredia, Lima, Peru., Korbenfeld E; Department of  Oncology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina., Krygier G; Department of  Oncology, Universitary Hospital de Clínicas, Montevideo, Uruguay., Mattar A; Director of Mastology Center, Centro de Referência da Saúde da Mulher, Hospital da Mulher, São Paulo, Brazil., De Pierro AN; Department of Surgery, Unit of Mastology, Hospital J.A. Fernandez, Buenos Aires City, Argentina., Borrego MR; Medical Oncology Service, Hospital Universitario Virgen del Rocío, Seville, Spain., Villarreal C; Head, Department of Medical Oncology, Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico.
Publikováno v: Journal of surgical oncology [J Surg Oncol] 2024 Aug; Vol. 130 (2), pp. 166-187. Date of Electronic Publication: 2024 Jun 24.
Zobrazit plný text záznamu
8
Akademický článek
Use of Antibody–Drug Conjugates in the Early Setting of Breast Cancer.
Autor: Koukoutzeli, Chrysanthi1 (AUTHOR), Trapani, Dario1,2 (AUTHOR), Ascione, Liliana1,2 (AUTHOR), Kotteas, Elias3 (AUTHOR), Marra, Antonio1 (AUTHOR), Criscitiello, Carmen1,2 (AUTHOR), Curigliano, Giuseppe1,2 (AUTHOR) giuseppe.curigliano@ieo.it
Publikováno v: Clinical Medicine Insights: Oncology. 6/17/2024, p1-16. 16p.
Zobrazit plný text záznamu
9
Akademický článek
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel.
Autor: Nitz UA; West German Study Group GmbH, Moenchengladabach; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach., Gluz O; West German Study Group GmbH, Moenchengladabach; Evangelical Hospital Johanniter Bethesda, Breast Center Niederrhein, Moenchengladbach; University of Cologne, Cologne. Electronic address: oleg.gluz@wsg-online.com., Christgen M; Institute of Pathology, Medical School Hannover, Hannover., Grischke EM; Department of Gynecology and Obstetrics, University Clinics Tuebingen, Tuebingen., Augustin D; Breast Center Ostbayern, Deggendorf., Kuemmel S; Breast Center, Clinics Essen-Mitte, Essen., Braun M; Rotkreuz Clinics Munich Breast Center, Munich., Potenberg J; Department of Oncology Evangelical Waldkrankenhaus Berlin, Berlin., Kohls A; Department of Gynecology and Obstetrics, Evangelical Hospital, Ludwigsfelde., Krauss K; Department of Gynecology and Obstetrics, University Clinics RWTH, Aachen., Stefek A; Breast Center, Evangelical Hospital Johanniter, Stendal., Schumacher C; Breast Center, St. Elisabeth Hospital Cologne, Cologne., Forstbauer H; Oncology Practice Network, Troisdorf., Reimer T; Department of Gynecology and Obstetrics, University Clinics Rostock, Suedstadt., Fischer H; Breast Center, Evangelical Hospital Gelsenkirchen, Gelsenkirchen., Liedtke C; Department of Gynecology and Obstetrics, University Clinics Schleswig-Holstein/Campus Luebeck, Luebeck; Charite Berlin., Wuerstlein R; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich., Schumacher J; Palleos Healthcare, Statistics, Wiesbaden, Germany., Kates R; West German Study Group GmbH, Moenchengladabach., Kreipe H; University of Cologne, Cologne., Harbeck N; West German Study Group GmbH, Moenchengladabach; Breast Center, Department of Gynecology and Obstetrics, University of Munich (LMU) and CCCLMU, Munich.
Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Nov 01; Vol. 28 (11), pp. 2768-2772.
Zobrazit plný text záznamu
10
Akademický článek
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET.
Autor: Harbeck N; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Gluz O; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Christgen M; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Kates RE; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Braun M; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Küemmel S; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Schumacher C; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Potenberg J; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Kraemer S; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Kleine-Tebbe A; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Augustin D; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Aktas B; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Forstbauer H; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Tio J; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., von Schumann R; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Liedtke C; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Grischke EM; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Schumacher J; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Wuerstlein R; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Kreipe HH; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany., Nitz UA; Nadia Harbeck, Ludwig Maximilians University Hospital of Munich; Michael Braun, Red Cross Hospital Munich; Rachel Wuerstlein, University Hospital Munich, Munich; Nadia Harbeck, Oleg Gluz, Ronald Ernest Kates, Rachel Wuerstlein, and Ulrike Anneliese Nitz, The West German Study Group; Oleg Gluz, Raquel von Schumann, and Ulrike Anneliese Nitz, Evangelical Hospital Bethesda, Mönchengladbach; Matthias Christgen and Hans Heinrich Kreipe, Hannover Medical School, Hannover; Sherko Küemmel, Kliniken Essen-Mitte; Bahriye Aktas, Essen University Hospital, Essen; Claudia Schumacher, St Elisabeth-Krankenhaus, Stefan Kraemer, University Clinic, Cologne; Jochem Potenberg, Evangelical Waldkrankenhaus, Anke Kleine-Tebbe, DRK Kliniken, Berlin; Doris Augustin, Clinic Deggendorf, Deggendorf; Helmut Forstbauer, Onkologie Rheinsieg, Troisdorf; Joke Tio, University Hospital Münster, Münster; Cornelia Liedtke, University of Lübeck, Lübeck; Eva-Maria Grischke, University Hospital of Tübingen, Tübingen; and Johannes Schumacher, Palleos Healthcare Services, Wiesbaden, Germany.
Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Sep 10; Vol. 35 (26), pp. 3046-3054. Date of Electronic Publication: 2017 Jul 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje